Prognostic index for safety and compliance of docetaxel/ciplatin/5-fluorouracil (TPF) induction followed by radiochemotherapy (RT-CT) in 203 patients (pts) with unresectable squamous cell carcinoma of the head and neck (USCCHN)

Authors :: Christian Righini
Frederic Peyrade
Benjamin Lallemant
Cédric Mercier
Olivier Dassonville
Michel Beltran
Bruno Guelfucci
Marc Alfonsi
M. Zanaret
E. Chamorey
Source :: Journal of Clinical Oncology. 28:e16001-e16001
Publication Year :: 2010
Publisher :: American Society of Clinical Oncology (ASCO), 2010.
Abstract: e16001 Background: Although TPF is the standard induction regimen for USCCHN, frequent comorbidities in USCCHN pts limit its use. TPF may improve cure rate providing better patient screening. Study...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Cure rate
business.industry
Patient screening
Surgery
Regimen
Docetaxel
Fluorouracil
Internal medicine
medicine
Basal cell
business
Head and neck
medicine.drug

Full Text Access

Tools